958033-02-8

Basic information

• Product Name: 1-(3-bromophenyl)-2-phenylethan-1-amine
• Synonyms: 1-(3-bromophenyl)-2-phenylethan-1-amine
• CAS NO: 958033-02-8
• Molecular Weight: 276.176
• Mol File: 958033-02-8.mol

Chemical Properties

• CAS DataBase Reference: 1-(3-bromophenyl)-2-phenylethan-1-amine(CAS DataBase Reference)
• NIST Chemistry Reference: 1-(3-bromophenyl)-2-phenylethan-1-amine(958033-02-8)
• EPA Substance Registry System: 1-(3-bromophenyl)-2-phenylethan-1-amine(958033-02-8)

Safety Data

• Hazardous Substances Data: 958033-02-8(Hazardous Substances Data)

Upstream product

• 3132-99-8 m-bromobenzoic aldehyde 
• 6921-34-2 benzylmagnesium chloride 

Downstream Products

• 898802-76-1 (1R)-1-(3-bromophenyl)-2-phenylethan-1-amine 
• 898803-18-4 (1S)-1-(3-bromophenyl)-2-phenylethan-1-amine 
• 898803-15-1 [1-(3-bromo-phenyl)-2-phenyl-ethyl]-carbamic acid tert-butyl ester 

Relevant articles and documents

Orally bioavailable pyridine and pyrimidine-based Factor XIa inhibitors: Discovery of the methyl N-phenyl carbamate P2 prime group

Pyridine-based Factor XIa (FXIa) inhibitor (S)-2 was optimized by modifying the P2 prime, P1, and scaffold regions. This work resulted in the discovery of the methyl N-phenyl carbamate P2 prime group which maintained FXIa activity, reduced the number of H

THERAPEUTIC FLUOROETHYL UREAS

Compounds of the formula or a pharmaceutically acceptable salt thereof or a tautomer thereof, wherein A and B are as described herein, are useful for treating conditions afflicting mammals.

Substituted biaryl compounds as factor XIa inhibitors

The present invention provides compounds of Formula (I): or a stereoisomer, tautomer, pharmaceutically acceptable salt or solvate form thereof, wherein the variables A, L, Z, R3, and ring B are as defined herein. The compounds of Formula (I) ar